Clinical Trial Update: Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the HPV vaccine in healthy adult women aged 26 and older; study completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections
• Papillomavirus Infections

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus, Papillomavirus Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2012-03-27